Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 2, 31006
Abstract
We describe a mathematical/computational model for thrombin concentration gradients generated by procoagulant circulating tumor cells (CTCs) in flow. We examine how CTCs enhance blood coagulation as they diffuse tissue factor-dependent coagulation enzymes in a flow environment with vessel walls. Concentration fields of various enzymes, such as prothrombin and thrombin, diffuse, to, and from CTCs, respectively, as they propagate through the bloodstream. The diffusion-dependent generation of these enzymes sets up complex time-dependent concentration fields. The CTCs are modeled as diffusing point particles in an incompressible fluid, and we exploit exact analytical solutions based on three-dimensional Green’s functions for unbounded domains with one wall for high resolution numerical simulations. Time-dependent gradient trackers are used to highlight that concentration fields build-up (i) near boundaries (vessel walls), (ii) in regions surrounding the diffusing particles, and (iii) in complex time-dependent regions of the flow where fields associated with different particles overlap. Two flow conditions are modeled: no flow, and unidirectional constant flow. Our results indicate that the CTC-generated thrombin diffuses to and persists at the blood vessel wall, and that the spatial distribution of CTCs in flow determines local thrombin concentration. The magnitude of the diffusion gradient and local thrombin concentration is dependent upon bulk solution concentrations of coagulation factors within normal reported concentration ranges. Therefore, our model highlights the potential to determine patient-specific risks for CTC-induced hypercoagulability as a function of CTC number and individual patient concentration of coagulation factors.Keywords
This publication has 26 references indexed in Scilit:
- Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cellsPhysical Biology, 2011
- Contribution of platelets to tumour metastasisNature Reviews Cancer, 2011
- Systems Biology of Coagulation Initiation: Kinetics of Thrombin Generation in Resting and Activated Human BloodPLOS Computational Biology, 2010
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis, 2007
- Tissue Factor Initiated Blood CoagulationFrontiers in Bioscience-Landmark, 2006
- Malignancies, Prothrombotic Mutations, and the Risk of Venous ThrombosisJAMA, 2005
- Coagulation under Flow: The Influence of Flow-Mediated Transport on the Initiation and Inhibition of CoagulationPathophysiology of Haemostasis and Thrombosis, 2005
- Tissue Factor Pathway Inhibitor Reduces Experimental Lung Metastasis of B16 MelanomaThrombosis and Haemostasis, 2002
- Factor Xa Generation at the Surface of Cultured Rat Vascular Smooth Muscle Cells in an in Vitro Flow SystemJournal of Biomechanical Engineering, 1998
- FLOW AS A REGULATOR OF THE ACTIVATION OF FACTOR-X BY TISSUE FACTOR1988